Those Who Can, Teach: Pharma Stars
In the fourth part of our series on innovative education, a group of academic scientists from Norway, Denmark and the Czech Republic tell us how their new post-graduate bioanalytical course will produce the pharmaceutical scientists of the future.
In recent years, the complexity of molecules and delivery technologies used in the pharmaceutical industry has increased dramatically. Antibody–drug conjugates, polymer-conjugated small and large molecules, PLGA (poly(lactic-co-glycolic acid)) and hydrogel long-acting delivery products are just a few examples that illustrate this trend. For analytical chemists employed in the pharmaceutical industry, measurements related to new drug candidates and delivery technologies are becoming increasingly complex, and the challenges are even greater when the measurements need to be performed reliably in biological fluids. It is clear that the pharmaceutical industry of the future will demand analytical scientists with training at the highest level.
The scientific literature is rich in technical reports on new drug substances, new delivery technologies, and new analytical tools to support drug discovery and development – but discussions on how to teach future analytical scientists to navigate this constantly evolving landscape are notably lacking. The increasing use of highly complex medicinal products will also complicate bioanalysis outside the pharmaceutical industry, such as in hospital laboratories, analytical contract laboratories, forensic toxicology laboratories, and doping laboratories.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Login if you already created an account
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine